Foxconn sees 3% revenue drop for every NTD gain

At a recent earnings call, Foxconn chairman Young Liu acknowledged that tariffs and exchange rate fluctuations are posing mounting challenges…

Hiroca leverages Mexico, China plants to offset tariff impact and tap rising automotive demand

Following the US automotive tariff, the industry is reassessing production line adjustments. Notably, China is experiencing rising demand in its…

Taiwan launches large-scale computing infrastructure to drive AI development

As high-performance computing emerges as a defining force in global technology development, Taiwan is taking decisive steps to strengthen its…

Renesas expands in India with new offices and Meity-backed startup, academic partnerships

According to a press release on May 13, 2025, Renesas Electronics Corporation announced a partnership with India’s Ministry of Electronics…

AI computing power race continues amidst Trump tariff uncertainties

Global tech markets are closely monitoring AI server shipments and generative AI evolution as the industry enters a new phase…

D8AI’s no-code AI platform targets factory floors

Qisda, a leader in intelligent systems and IoT solutions, is positioning itself at the forefront of the rapidly expanding AI…

AI servers boost 2Q25 growth; Eikei continues to expand in Mexico’s automotive market

PCB manufacturer Eikei reported a slight decline in revenue for April due to delayed customer shipments and normal inventory adjustments.…

Memory market roars back: Adata’s 1Q profits soar, capacity maxed out through July

Adata Technology reported strong first-quarter 2025 results as memory prices rebounded and customer demand surged. Spot prices for both DRAM…

Honda postpones $11B EV production investment in Canada

The automaker is delaying the plan by at least two years while seeking increased production in the U.S. for multiple…

FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression

On May 14, 2025, the Food and Drug Administration granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis, AbbVie Inc.), a c-Met-directed…